FR2133979B1 - - Google Patents
Info
- Publication number
- FR2133979B1 FR2133979B1 FR7214052A FR7214052A FR2133979B1 FR 2133979 B1 FR2133979 B1 FR 2133979B1 FR 7214052 A FR7214052 A FR 7214052A FR 7214052 A FR7214052 A FR 7214052A FR 2133979 B1 FR2133979 B1 FR 2133979B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13818671A | 1971-04-21 | 1971-04-21 | |
US13618671A | 1971-04-21 | 1971-04-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2133979A1 FR2133979A1 (en) | 1972-12-01 |
FR2133979B1 true FR2133979B1 (en) | 1975-10-31 |
Family
ID=26834087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7214052A Expired FR2133979B1 (en) | 1971-04-21 | 1972-04-20 |
Country Status (4)
Country | Link |
---|---|
DE (1) | DE2219408A1 (en) |
FR (1) | FR2133979B1 (en) |
GB (1) | GB1356763A (en) |
NL (1) | NL7204972A (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6667300B2 (en) * | 2000-04-25 | 2003-12-23 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
LT2612862T (en) | 2004-05-13 | 2017-01-25 | Icos Corporation | Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
CN104042618B (en) | 2008-11-13 | 2018-02-16 | 吉利德卡利斯托加公司 | The treatment of malignant hematologic disease |
US9492449B2 (en) | 2008-11-13 | 2016-11-15 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
NZ595307A (en) | 2009-03-24 | 2013-11-29 | Gilead Calistoga Llc | Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
MX2011011036A (en) | 2009-04-20 | 2012-01-20 | Gilead Calistoga Llc | Methods of treatment for solid tumors. |
WO2011011550A1 (en) | 2009-07-21 | 2011-01-27 | Calistoga Pharmaceuticals Inc. | Treatment of liver disorders with pi3k inhibitors |
NZ705135A (en) * | 2010-05-26 | 2017-10-27 | Sunovion Pharmaceuticals Inc | Heteroaryl compounds and methods of use thereof |
EP3210984B1 (en) * | 2011-01-11 | 2019-06-19 | Sunovion Pharmaceuticals Inc. | Heteroaryl compounds and methods of use thereof |
CN106146506A (en) | 2012-03-05 | 2016-11-23 | 吉利德卡利斯托加公司 | (S) polymorph of 2 (1 (9H purine 6 base amino) propyl group) 5 fluorine 3 phenylquinazoline 4 (3H) ketone |
CA2934531C (en) | 2013-12-20 | 2020-02-25 | Gilead Calistoga Llc | Process methods for phosphatidylinositol 3-kinase inhibitors |
AU2014364414A1 (en) | 2013-12-20 | 2016-06-30 | Gilead Calistoga Llc | Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one |
AU2015274696B2 (en) | 2014-06-13 | 2018-09-27 | Gilead Sciences, Inc. | Phosphatidylinositol 3-kinase inhibitors |
CN111944340B (en) * | 2020-08-21 | 2022-08-05 | 无锡市乐卡新材料有限公司 | Salt-fog-resistant antirust coating |
-
1972
- 1972-04-13 NL NL7204972A patent/NL7204972A/xx unknown
- 1972-04-18 GB GB1791772A patent/GB1356763A/en not_active Expired
- 1972-04-20 DE DE19722219408 patent/DE2219408A1/en active Pending
- 1972-04-20 FR FR7214052A patent/FR2133979B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE2219408A1 (en) | 1972-10-26 |
NL7204972A (en) | 1972-10-24 |
FR2133979A1 (en) | 1972-12-01 |
GB1356763A (en) | 1974-06-12 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |